Skip to content

Electroretinogram and Retinal Vascular Changes After Cataract Surgery

Changes of Electrophysiology and Optical Coherence Tomography Angiography in Primary Open Angle Glaucoma After Phacoemulsification

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05871034
Enrollment
100
Registered
2023-05-23
Start date
2023-05-15
Completion date
2024-12-01
Last updated
2023-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Open Angle Glaucoma

Keywords

OCTA: optical coherence tomography angiography, ERG: electroretinogram, POAG: primary open Angle glaucoma, V/A: visual acuity, IOP: intra ocular pressure

Brief summary

To compare electrophysiological and Optical coherence tomography angiography of optic disc and macula changes after uneventful phacoemulsification between normal and cataractus patients with primary open angle glaucoma.

Detailed description

* Study design: A prospective, non randomized, interventional, comparative study, control based study. * Location: Ophthalmology department, Sohag university hospital. In this prospective study, aiming to investigate Optical coherence tomography angiography and electrophysiological changes after cataract surgery in normal and patients with POAG with cataract 1 day before operation, 1 week and 3 months postoperatively. * Methodology The study will include 50 patients with primary open angle glaucoma associated with cataract and 50 patients have cataract without glaucoma. Preoperative and postoperative evaluation: All patients will be subjected to the following: * History taking including age, gender, family history, systemic diseases, previous medications or ophthalmic surgery. * Detailed ophthalmological examination including: Uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA) by Snellen's fraction and converted into logarithm of the minimal angle of resolution LogMAR, refraction, keratometry, slit lamp biomicroscopy for anterior segment, IOP measurement by applanation tonometer, and posterior segment (Fundus) examination. * Examination of the angle of anterior chamber by goniolens. * OCTA disc and macula * Pattern ERG and multifocal ERG Surgical techniques: Patients will be subdivided into two groups: Group (A): normal Patients will undergo standard phacoemulsification surgery. Group (B): Patients with POAG will undergo standard phacoemulsification surgery. \* phaco technology by using (WHITESTAR SIGNATURE PRO, Abbott, USA) * OCT angiography will be done by (Optovue, Inc., Fremont, California, USA). * Electrophysiology will be done by (Roland consult Retimap, Germany)

Interventions

PROCEDUREphacoemulsification

cataract extraction

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients aged: 45-65 years old with cataract density doesn't interfere with Pre-operative imaging (N1-N2). * Patients with primary open angle diagnosed for at least 2 years with glaucoma treatment associated with cataract (N1-N2).

Exclusion criteria

s▪ patient with PACG. * Previous intraocular surgery. * Associated ocular or intra ocular inflammation * Previous history of eye trauma. * Associated intraocular pathology

Design outcomes

Primary

MeasureTime frameDescription
Pattern and multifocal electroretinogram and Optical coherence tomography angiography of optic disc and macula changes after phacoemulsification in primary open angle glaucomabefore operation and 1st month, 3rd month post operativeelectrophysiology and optical coherence tomography angiography changes

Secondary

MeasureTime frameDescription
Visual acuity and intra ocular pressure changesbefore operation and 1st month, 3rd month post operativevisual acuity and intraocular pressure changes

Contacts

Primary Contactshorouq abdelrahman
shorouqabdelrahman2015@gmail.com01016685915
Backup Contactalaa mahmoud
01060422011

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026